Nephrotoxicity from cancer immunotherapy

G. M. Dosik; J. U. Gutterman; E. M. Hersh; M. Akhtar; T. Sonoda; R. G. Horn

doi:10.7326/0003-4819-89-1-41

Nephrotoxicity from cancer immunotherapy

G. M. Dosik, J. U. Gutterman, E. M. Hersh, M. Akhtar, T. Sonoda, R. G. Horn

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.

Original language	English (US)
Pages (from-to)	41-46
Number of pages	6
Journal	Unknown Journal
Volume	89
Issue number	1
DOIs	https://doi.org/10.7326/0003-4819-89-1-41
State	Published - 1978
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-89-1-41

Cite this

@article{7293343a3ae043e2b3b172614ea904ab,

title = "Nephrotoxicity from cancer immunotherapy",

abstract = "Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.",

author = "Dosik, {G. M.} and Gutterman, {J. U.} and Hersh, {E. M.} and M. Akhtar and T. Sonoda and Horn, {R. G.}",

year = "1978",

doi = "10.7326/0003-4819-89-1-41",

language = "English (US)",

volume = "89",

pages = "41--46",

journal = "Unknown Journal",

issn = "0375-9474",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Nephrotoxicity from cancer immunotherapy

AU - Dosik, G. M.

AU - Gutterman, J. U.

AU - Hersh, E. M.

AU - Akhtar, M.

AU - Sonoda, T.

AU - Horn, R. G.

PY - 1978

Y1 - 1978

N2 - Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.

AB - Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0017826289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017826289&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-89-1-41

DO - 10.7326/0003-4819-89-1-41

M3 - Article

C2 - 666183

AN - SCOPUS:0017826289

SN - 0375-9474

VL - 89

SP - 41

EP - 46

JO - Unknown Journal

JF - Unknown Journal

IS - 1

ER -

Nephrotoxicity from cancer immunotherapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this